COGZF Company Profile and Key Details

Cogstate Limited (OTC:COGZF) closed at $1.43 USD, losing -$0.10 (-6.54%) from the previous close of $1.53. The stock is currently mid-range between its 52-week high and low $0.63 and $2.10. With a market capitalization of about $244.90 million, Cogstate Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~0.02). Key stats such as the average daily volume over the past year has been around 1.61 thousand shares, trading with heavier-than-usual volume. Headquartered in Melbourne, VIC, Cogstate Limited operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Bradley John O'Connor, the company employs approximately 147 people and listed since April 05, 2010. Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions.

Cogstate Limited last paid a dividend of 0.01 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.53. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Cogstate Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Cogstate Limited trading at a premium to the broader market with a P/E of 22.89.

Cogstate Limited trades at a P/E ratio of 22.89, slightly below the S&P 500 average, with a price-to-sales ratio of 4.38 and a price-to-book ratio of 7.72 trading at moderately above to book value. The P/FCF stands at 19.59, also above market averages.